Effectiveness of low-dose nadolol for ventricular arrhythmiasMORGANROTH, J; DUCHIN, K. L.The American journal of cardiology. 1986, Vol 58, Num 3, pp 273-278, issn 0002-9149Article

The effect of captopril on renal hemodynamics in hypertensive patientsDUCHIN, K. L; WILLARD, D. A.Journal of clinical pharmacology. 1984, Vol 24, Num 8-9, pp 351-359, issn 0091-2700Article

Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patientsGEHR, T. W. B; SICA, D. A; GRASELA, D. M et al.European journal of clinical pharmacology. 1991, Vol 41, Num 2, pp 165-169, issn 0031-6970Article

Bioequivalence of a highly variable drug : An Experience with nadololBUICE, R. G; SUBRAMANIAN, V. S; DUCHIN, K. L et al.Pharmaceutical research. 1996, Vol 13, Num 7, pp 1109-1115, issn 0724-8741Article

Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseasesDUCHIN, K. L; MCKINSTRY, D. N; COHEN, A. I et al.Clinical pharmacokinetics. 1988, Vol 14, Num 4, pp 241-259, issn 0312-5963Article

Elimination kinetics of captopril in patients with renal failureDUCHIN, K. L; PIERIDES, A. M; HEALD, A et al.Kidney international. 1984, Vol 25, Num 6, pp 942-947, issn 0085-2538Article

Once-daily fosinopril in the treatment of hypertensionANDERSON, R. J; DUCHIN, K. L; GORE, R. D et al.Hypertension (Dallas, Tex. 1979). 1991, Vol 17, Num 5, pp 636-642, issn 0194-911X, 7 p.Article

The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin systemQUILLEY, J; DUCHIN, K. L; HUDES, E. M et al.Journal of hypertension. 1987, Vol 5, Num 1, pp 121-128, issn 0263-6352Article

The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patientsGEHR, T. W. B; SICA, D. A; GRASELA, D. M et al.European journal of clinical pharmacology. 1993, Vol 45, Num 5, pp 431-436, issn 0031-6970Article

Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjectsDUCHIN, K. L; WACLAWSKI, A. P; TU, J. I et al.Journal of clinical pharmacology. 1991, Vol 31, Num 1, pp 58-64, issn 0091-2700, 7 p.Article

Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney goldblatt hypertensionICHIKAWA, I; FERRONE, R. A; DUCHIN, K. L et al.Circulation research. 1983, Vol 53, Num 5, pp 592-602, issn 0009-7330Article

Phase I trial of orally administered pentosan polysulfate in patients with advanced cancerMARSHALL, J. L; WELLSTEIN, A; RAE, J et al.Clinical cancer research. 1997, Vol 3, Num 12, pp 2347-2354, issn 1078-0432, 1Article

Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virusZHOU, X.-J; SQUIRES, K; PAN-ZHOU, X.-R et al.Journal of clinical pharmacology. 1997, Vol 37, Num 3, pp 201-213, issn 0091-2700Article

Pharmacokinetics of fosinopril in patients with various degrees of renal functionKA KIT HUI; DUCHIN, K. L; KRIPALANI, K. J et al.Clinical pharmacology and therapeutics. 1991, Vol 49, Num 4, pp 457-467, issn 0009-9236Article

Disposition of fosinopril sodium in healthy subjectsSINGHVI, S. M; DUCHIN, K. L; MORRISON, R. A et al.British journal of clinical pharmacology. 1988, Vol 25, Num 1, pp 9-15, issn 0306-5251Article

Pharmacokinetics of iopamidol after intrathecal administration in humansDUCHIN, K. L; DRAYER, B. P; ROSS, M et al.American journal of neuroradiology. 1986, Vol 7, Num 5, pp 895-898, issn 0195-6108Article